| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Merus N.V. | President, CEO & PEO, Director | Share Option (right to buy) | 0 | $4,226,622 | $13.52 | 12 Dec 2025 | Direct |
| Q32 Bio Inc. | Director | Stock Option (Right to Buy) | 20,363 | $55,998 | $2.75 | 15 Jan 2026 | Direct |
| Merus N.V. | President, CEO & PEO, Director | Common Shares | 0 | $0 | $97.00 | 12 Dec 2025 | Ante S Lundberg Qualified Annuity Interest Trust XI |
| Merus N.V. | President, CEO & PEO, Director | Common Shares | 0 | $0 | $97.00 | 12 Dec 2025 | Ante S Lundberg Qualified Annuity Int Trust X |
| Merus N.V. | President, CEO & PEO, Director | Common Shares | 0 | $0 | $97.00 | 12 Dec 2025 | Emily Lundberg 2018 Irrevocable Trust |
| Merus N.V. | President, CEO & PEO, Director | Common Shares | 0 | $0 | $97.00 | 12 Dec 2025 | Katrina Lundberg 2018 Irrevocable Trust |
| Merus N.V. | President, CEO & PEO, Director | Common Shares | 0 | $0 | $97.00 | 12 Dec 2025 | Kristian Ante Lundberg 2018 Irrevocable Trust |
| Merus N.V. | President, CEO & PEO, Director | Common Shares | 0 | $0 | $97.00 | 12 Dec 2025 | Madeleine Lundberg 2018 Irrevocable Trust |
| Vor Biopharma Inc. | Director | Stock Option (Right to Buy) | 30,000 | 22 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| QTTB | Q32 Bio Inc. | 15 Jan 2026 | 1 | +$55,998 | 4 | Director | 30 Jan 2026, 19:00 |
| MRUS | Merus N.V. | 12 Dec 2025 | 12 | -$8,093,195 | 4 | President, CEO & PEO, Director | 12 Dec 2025, 18:59 |
| MRUS | Merus N.V. | 25 Nov 2025 | 11 | $0 | 4 | President, CEO & PEO, Director | 28 Nov 2025, 16:30 |
| QTTB | Q32 Bio Inc. | 23 Oct 2025 | 1 | $0 | 4 | Director | 27 Oct 2025, 21:34 |
| VOR | Vor Biopharma Inc. | 22 May 2025 | 1 | $0 | 4 | Director | 23 May 2025, 17:45 |
| MRUS | Merus N.V. | 17 Apr 2025 | 4 | $0 | 4 | President, CEO & PEO, Director | 21 Apr 2025, 16:05 |
| MRUS | Merus N.V. | 19 Feb 2025 | 2 | $0 | 4 | President, CEO & PEO, Director | 21 Feb 2025, 16:05 |
| MRUS | Merus N.V. | 13 Feb 2025 | 2 | +$399,968 | 4 | President, CEO & PEO, Director | 18 Feb 2025, 17:43 |
| MRUS | Merus N.V. | 29 Jan 2025 | 1 | $0 | 4 | President, CEO & PEO, Director | 31 Jan 2025, 16:31 |
| QTTB | Q32 Bio Inc. | 15 Jan 2025 | 12 | $0 | 4 | Director | 26 Feb 2025, 21:52 |
| QTTB | Q32 Bio Inc. | 25 Sep 2024 | 1 | $0 | 4 | Director | 27 Sep 2024, 21:57 |
| VOR | Vor Biopharma Inc. | 23 May 2024 | 1 | $0 | 4 | Director | 28 May 2024, 16:10 |
| MRUS | Merus N.V. | 07 May 2024 | 1 | $0 | 4 | President, CEO & PEO, Director | 09 May 2024, 16:30 |
| QTTB | Homology Medicines, Inc. | 25 Mar 2024 | 1 | $0 | 4 | Director | 27 Mar 2024, 17:25 |
| QTTB | Homology Medicines, Inc. | 25 Mar 2024 | 0 | $0 | 3 | Director | 27 Mar 2024, 17:14 |
| VOR | Vor Biopharma Inc. | 26 May 2023 | 1 | $0 | 4 | Director | 02 Jun 2023, 16:34 |
| MRUS | Merus N.V. | 02 Feb 2023 | 1 | $0 | 4 | President, CEO & PFO, Director | 03 Feb 2023, 15:23 |
| MRUS | Merus N.V. | 03 Nov 2022 | 1 | +$211,431 | 4 | President, CEO & PFO, Director | 03 Nov 2022, 14:07 |
| MRUS | Merus N.V. | 22 Aug 2022 | 0 | $0 | 4/A | President, CEO & PFO, Director | 24 Oct 2022, 16:24 |
| MRUS | Merus N.V. | 19 Aug 2022 | 1 | +$16,187 | 4 | President, CEO & PFO, Director | 22 Aug 2022, 15:02 |
| MRUS | Merus N.V. | 12 Jul 2022 | 1 | +$99,685 | 4 | President, CEO & PFO, Director | 13 Jul 2022, 10:13 |
| VOR | Vor Biopharma Inc. | 14 Jun 2022 | 1 | $0 | 4 | Director | 16 Jun 2022, 17:07 |
| MRUS | Merus N.V. | 31 Jan 2022 | 1 | $0 | 4 | President, CEO & PFO, Director | 02 Feb 2022, 13:02 |
| MRUS | Merus N.V. | 02 Aug 2021 | 4 | $0 | 4 | President, CEO & PFO, Director | 04 Aug 2021, 15:56 |